BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22907255)

  • 21. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.
    Pokoyski C; Lienen T; Rother S; Schock E; Plege-Fleck A; Geffers R; Schwinzer R
    Genes Immun; 2015 Dec; 16(8):519-27. PubMed ID: 26355564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer.
    Mahalingam J; Lin CY; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Lin YC
    PLoS One; 2014; 9(9):e108554. PubMed ID: 25268580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD45RA-Foxp3(low) non-regulatory T cells in the CCR7-CD45RA-CD27+CD28+ effector memory subset are increased in synovial fluid from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Nishimura K; Miura Y; Kurosaka M; Kumagai S; Morinobu A
    Cell Immunol; 2014 Jul; 290(1):96-101. PubMed ID: 24952375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration.
    Beyer M; Schumak B; Weihrauch MR; Andres B; Giese T; Endl E; Knolle PA; Classen S; Limmer A; Schultze JL
    PLoS One; 2012; 7(1):e30422. PubMed ID: 22276195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1.
    Maccalli C; Di Cristanziano V; Fodale V; Corsi D; D'Agostino G; Petrangeli V; Laurenti L; Guida S; Mazzocchi A; Arienti F; Perrone MP; Castelli C; Rivoltini L; Zagonel V; Tartaglia M; Parmiani G; Belardelli F
    Clin Cancer Res; 2008 Nov; 14(22):7292-303. PubMed ID: 18974390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
    Li L; Lao SH; Wu CY
    Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell subsets and colorectal cancer: discerning the good from the bad.
    Scurr M; Gallimore A; Godkin A
    Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
    Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
    J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy.
    Kumar S; Naqvi RA; Ali R; Rani R; Khanna N; Rao DN
    Mol Immunol; 2013 Dec; 56(4):513-20. PubMed ID: 23911408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T cell inflammation.
    Mao H; Pan F; Wu Z; Wang Z; Zhou Y; Zhang P; Gou M; Dai G
    Int Immunopharmacol; 2017 Aug; 49():95-101. PubMed ID: 28558303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
    Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
    Cancer Immunol Immunother; 2007 Sep; 56(9):1429-42. PubMed ID: 17265021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
    De Somer L; Fevery S; Bullens DM; Rutgeerts O; Lenaerts C; Mathieu C; Boon L; Kasran A; Waer M; Billiau AD
    Immunol Lett; 2010 Sep; 133(1):49-53. PubMed ID: 20600326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.
    Roncarolo MG; Gregori S; Levings M
    Novartis Found Symp; 2003; 252():115-27; discussion 127-31, 203-10. PubMed ID: 14609215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
    Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
    Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.